Cellectis Logo.png
Cellectis Provides Business Update and Reports Financial Results for First Quarter 2021
May 06, 2021 16:30 ET | Cellectis Inc.
Enrollment ongoing in three Cellectis-sponsored Phase 1 dose-escalation clinical studies BALLI-01 in r/r B-ALL patients, AMELI-01 in r/r AML patients and MELANI-01 in r/r MM patients in 15 US clinical...
Inotiv_Logo_CMYK.png
Inotiv, Inc. Announces Closing of Public Offering and Full Exercise of Underwriter’s Option to Purchase Additional Shares
April 23, 2021 11:15 ET | Inotiv, Inc.
WEST LAFAYETTE, Ind., April 23, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv_Logo_CMYK.png
Inotiv, Inc. Announces Expansion of Pharmacology and Pathology Offerings with Agreement to Purchase Bolder BioPATH, Inc.
April 16, 2021 08:33 ET | Inotiv, Inc.
WEST LAFAYETTE, Ind., April 16, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading provider of non-clinical and analytical contract research...
Inotiv_Logo_CMYK.png
Inotiv, Inc. Enhances Histopathology Offering with Announcement of Agreement to Purchase HistoTox Labs, Inc.
April 13, 2021 16:35 ET | Inotiv, Inc.
WEST LAFAYETTE, Ind., April 13, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading provider of nonclinical and analytical contract research...
abcam-grey.png
Abcam and MEDx extend precision medicine strategic partnership
April 12, 2021 05:00 ET | Abcam
Building on existing three-year collaborationFocusing on co-development of companion and in vitro diagnostic kits to support demand in China CAMBRIDGE, United Kingdom and SHANGHAI, China, April 12,...
Cellectis Logo.png
Cellectis Completes Sale of $47 million through its ATM program
April 09, 2021 02:30 ET | Cellectis Inc.
NEW YORK, April 09, 2021 (GLOBE NEWSWIRE) -- Cellectis S.A. (NASDAQ: CLLS – EURONEXT GROWTH: ALCLS) (the “Company”), a clinical-stage biotechnological company employing its core proprietary...
lsif-logo-default (1).png
Life Sciences Companies Investors Presentations Now Available for On-Demand Viewing
March 29, 2021 08:35 ET | Life Sciences Investor Forum
NEW YORK, March 29, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced that the presentations from the March 25th conference are now available for on-demand viewing at...
Kinnate_LogoColor@10x.png
Kinnate Biopharma Inc. Announces Its Addition to the Russell 2000® Index
March 19, 2021 16:05 ET | Kinnate Biopharma
SAN FRANCISCO and SAN DIEGO, March 19, 2021 (GLOBE NEWSWIRE) -- Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a biopharmaceutical company focused on the discovery and development of small...
lsif-logo-default (1).png
Virtual Conference for Life Sciences Companies Broadcast Live March 25th, 2021
March 19, 2021 08:35 ET | Life Sciences Investor Forum
NEW YORK , March 19, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors and industry professionals...
BrightInsight and AstraZeneca Collaborate to Enhance Disease Management
March 16, 2021 08:30 ET | BrightInsight
SAN JOSE, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- BrightInsight, Inc., provider of the leading global regulated digital health platform for biopharma and medtech, announced today the launch of...